PPOS versus GnRH antagonist IVF protocols for women with PCOS
Official title: A Comparative Study of In Vitro Fertilization Outcomes Between PPOS and Antagonist Protocols in Women With Polycystic Ovary Syndrome
Run by Hanoi General Hospital (Vietnam) · NCT07394530 · Data updated 2026-11-12
This trial will test whether a progestin-primed ovarian stimulation (PPOS) protocol or a GnRH antagonist protocol gives better IVF outcomes for women aged 18–40 with PCOS.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | Women only |
| Enrollment | 400 (estimated) |
| Sponsor | Hanoi General Hospital (Vietnam) Academic / other |
| Locations | 1 site (Hanoi, Hanoi) |
| Status | Recruiting |
| Started | January 20, 2026 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2028 |
| Registry record updated | August 5, 2026 |
| Trial ID | NCT07394530 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18–40 diagnosed with PCOS by the modified Rotterdam criteria who are planning IVF and whose partners have normal or only mildly to moderately abnormal sperm are the intended participants.
✕Probably not a fit
Women with significant uterine abnormalities, major prior ovarian or uterine surgery affecting reserve or structure, or other exclusionary conditions are unlikely to benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Women meeting modified Rotterdam criteria for PCOS who are indicated for IVF will receive one of two controlled ovarian stimulation approaches: a progestin-primed ovarian stimulation (PPOS) protocol or a GnRH antagonist protocol. Key IVF outcomes such as number of oocytes retrieved, fertilization and embryo quality, pregnancy rates, and rates of complications (including ovarian hyperstimulation) will be recorded and compared between groups. Eligible participants are 18–40 years old, have PCOS, and a partner with normal or mildly-to-moderately abnormal sperm parameters; major uterine or prior ovarian surgery that impairs outcomes are exclusionary. The protocol is conducted at Hanoi General Hospital with standard IVF monitoring and follow-up visits.
Why it matters
Potential benefit: If successful, the results could help clinicians choose the stimulation method that yields more eggs or higher pregnancy rates while reducing complications for women with PCOS.
How similar studies have gone: Previous studies comparing PPOS and antagonist protocols have generally reported similar embryo yield and pregnancy rates, with some evidence that PPOS can reduce ovarian hyperstimulation risk, though results are mixed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women aged 18-40 years * Diagnosed with polycystic ovary syndrome (PCOS) according to the modified Rotterdam criteria (2004) (≥2 of 3: oligo/anovulation, hyperandrogenism, or polycystic ovarian morphology on ultrasound) * Indicated for in vitro fertilization (IVF) due to PCOS alone or PCOS with other infertility factors (e.g., tubal factor, previous failed IUI) * Eligible for controlled ovarian stimulation for IVF * Husband/partner with normal sperm parameters or mild to moderate oligoasthenoteratozoospermia (OAT) * Willing and able to provide written informed consent and comply with study procedures. Exclusion Criteria: * Uterine abnormalities that may impair implantation or pregnancy outcomes, including congenital uterine malformations, large fibroids distorting the uterine cavity, adenomyosis, or severe intrauterine pathology. * History of major ovarian or uterine surgery affecting ovarian reserve or uterine structure (e.g., ovarian cystectomy, endometriosis surgery, myomectomy, unilateral oophorectomy) * History of recurrent pregnancy loss (≥3 spontaneous miscarriages) * Known chromosomal abnormalities in either partner * Inability to adhere to study protocol or follow-up procedures
Where it's running
-
Hanoi General Hospital
Hanoi, Hanoi, Vietnam Recruiting
Study contacts
- Principal investigator: Phuong Duy Nguyen, MD, MS — Hanoi General Hospital
- Study coordinator: Phuong Duy Nguyen, MD, MSc - PI
- Email: nguyenduyphuongncs44@gmail.com
- Phone: +84 986656835
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using LC-MS/MS to profile androgens for PCOS diagnosis
This study tests whether LC-MS/MS measurement of androgen profiles can help diagnose PCOS in women compared with healthy controls.
-
Brown adipose tissue responses in PCOS with infrared thermography and inositol
This study tests whether brown fat activity, measured by infrared skin temperature and UCP-1 levels, differs among women with PCOS (normal weight or overweight/obese) and healthy controls, and whether 12 weeks of inositol changes those responses in overweight/obese PCOS participants.
-
Risk tool for blood-clotting problems in adolescents and women with PCOS
This project will try to build a risk model to spot decreased protein C or S and other clotting abnormalities in females aged 14–45 who have PCOS.
-
Blocking RANKL with denosumab to protect ovarian follicles
This trial will test whether giving denosumab, a drug that blocks RANKL, can help protect follicle development in women with infertility who are undergoing assisted reproduction.
-
Effect of a 21-day comprehensive spa program on female infertility
This study tests whether a 21-day spa treatment can impact hormonal profiles and reproductive outcomes in women ages 20-40 with infertility.
-
Endometrial immune profile changes after putting your own PRP into the uterus
This test will try whether putting a person's own platelet-rich plasma (PRP) into the uterus improves the uterine immune profile, thickness, hormone levels, and pregnancy rates for people undergoing IVF with euploid embryo transfer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.